浙江奥托康制药集团股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
74
NMPA:74
Drug Approvals
Amikacin Sulfate Injection
- Product Name
- 硫酸阿米卡星注射液
- Approval Number
- 国药准字H33020287
- Approval Date
- Jun 22, 2021
NMPA
Erythromycin Ethylsuccinate
- Product Name
- 琥乙红霉素
- Approval Number
- 国药准字H33020152
- Approval Date
- Jul 3, 2020
NMPA
Erythromycin Ethylsuccinate Granules
- Product Name
- 琥乙红霉素颗粒
- Approval Number
- 国药准字H33020145
- Approval Date
- Jun 29, 2020
NMPA
Metronidazole and Sodium Chloride Injection
- Product Name
- 甲硝唑氯化钠注射液
- Approval Number
- 国药准字H33020289
- Approval Date
- Jun 29, 2020
NMPA
Potassium Chloride Injection
- Product Name
- 氯化钾注射液
- Approval Number
- 国药准字H33020151
- Approval Date
- Jun 29, 2020
NMPA
Ciprofloxacin Lactate and Sodium Chloride Injection
- Product Name
- 乳酸环丙沙星氯化钠注射液
- Approval Number
- 国药准字H10950051
- Approval Date
- Jun 23, 2020
NMPA
Ciprofloxacin Lactate and Sodium Chloride Injection
- Product Name
- 乳酸环丙沙星氯化钠注射液
- Approval Number
- 国药准字H10950053
- Approval Date
- Jun 23, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
No trials found
News
No news found